Latest Coagulopathy Stories
FLINT, Mich., Nov. 4, 2014 /PRNewswire/ -- American Homecare Federation, a Diplomat company (NYSE: DPLO), is celebrating 25 years of business this year.
An Educational Program Based on the Findings From the Hemophilia Experiences, Results, and Opportunities (HERO) Study Launched at NHF's 66th Annual Meeting NEW YORK and PLAINSBORO,
National Hemophilia Foundation Encourages Patient Community to Take an Active Part in Strategies, Policies, and Programs Directly Affecting Their Lives at 66th Annual Meeting in Washington, DC
Randy Fenninger to Lead Organization With Strategic Focus Aimed at Increasing Recognition of Life-Threatening Blood Clots and Their Impact on Public Health Rockville,
First Recombinant Treatment Approved in US for Patients With GT With Refractoriness to Platelet Transfusions, With or Without Antibodies to Platelets PLAINSBORO, N.J., July 7, 2014 /PRNewswire/
This month Chris Bombardier will attempt to be the first person with hemophilia to scale Mt.
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- Three-year commitment of up to 20 million units per year of blood clotting medicines to treat hemophilia patients in developing countries BARCELONA, Spain, April 17, 2014 /PRNewswire/
6.9 million people have a bleeding disorder.
Defective blood coagulation is one of the leading causes of preventable death in patients who have suffered trauma or undergone surgery.